ALBANY, N.Y., March 8, 2021 /PRNewswire/ — Genomic studies have been transformed by next-generation sequencing. With dwindling prices and an increasingly growing number and variety of sequencing applications, NGS technology has improved considerably. The growth of the global NGS sample preparation market is being fuelled by better reimbursement scenario for NGS-based diagnostic tests, lower cost of sequencing, and developments in these systems. Although the costs of NGS have decreased to some degree, they have not yet reached a point where they can be widely adopted in developing parts of the world. This is likely to constitute a major impediment toward business expansion.
Surveillance based on sequencing is proving to be a useful tool for the detection of new coronavirus strains and various other unidentified pathogens. As a result, India’s launch of Covid-19 vaccines has reduced the burden on firms in the global NGS sample preparation market to identify mutations in the strain. In addition to that, companies like Illumina, a biotechnology corporation based in the United States, continue to provide useful information to researchers and public health authorities on the virus’s global transmission routes.
Request for Analysis of COVID-19 Impact on NGS Sample Preparation Market – https://www.transparencymarketresearch.com/covid19.php
Firms in the NGS sample preparation market are stepping up their efforts to find viral mutations that could possibly compromise…